Articles
Qiagen Evaluates Strategic Alternatives Amid Renewed Acquisition Interest
German molecular diagnostics company engages advisers and considers sale after prior deal attempts falter
Qiagen N.V., a leading German life sciences tools and molecular diagnostics firm, is reviewing strategic options including a potential sale as it enga...
Analyst Picks Highlight Tech and Utility Stocks Amid Market Fluctuations
Experts weigh in on Toast, Southern Company, and software ETFs as earnings approach
During a recent financial segment, several market analysts shared their investment recommendations focusing on technology and utility sectors. Toast, ...
Market Sentiment Turns Negative as Netflix and Several Biopharma Stocks See Pre-Market Declines
Investors React to Mixed Earnings and Large Equity Offerings Ahead of Market Open
U.S. stock futures showed a mixed range of movements early Wednesday, with notable declines in key tech and biopharmaceutical shares. Netflix shares r...
Warren Buffett's Enduring Investment Criterion for Selecting Stocks in 2026
Applying the Oracle of Omaha’s principle of understanding businesses before buying shares
Warren Buffett recently stepped down as CEO of Berkshire Hathaway, leaving behind a prolific investment legacy characterized by a disciplined approach...
Treasury Secretary Criticizes Defense Industry Over Contract Delays and Corporate Practices
Concerns Raised About Production Backlogs, Executive Pay, and Investment Priorities Among Major U.S. Defense Firms
U.S. Treasury Secretary Scott Bessent publicly condemned leading defense contractors for substantial contract fulfillment delays, excessive executive ...
Johnson & Johnson Projects Near $100 Billion in Revenue for Fiscal 2026
Strong Q4 2025 Earnings and Diverse Portfolio Drive Upward Sales Outlook
Johnson & Johnson reported robust adjusted earnings per share and revenue growth in the fourth quarter of 2025, exceeding Wall Street estimates. The c...
TE Connectivity Posts Strong Quarterly Earnings Amid Robust AI and EV Demand
Company Reports Record Orders and Sales Growth, Supported by Industrial and Transportation Segments
TE Connectivity Plc delivered impressive fiscal first-quarter results for 2026, marked by a 33% rise in adjusted earnings per share and a 22% increase...
Sea Ltd. — A Tactical Long on Re-acceleration and Optionality
Use a disciplined swing entry around the 120 area; asymmetric upside if Shopee and SeaMoney keep improving.
Sea Limited (SE) looks like a classic growth-with-profitability optionality setup: strong founder alignment, meaningful market-share in Southeast Asia...
Clarity Act Sparks Division Among Crypto Leaders Over Regulatory Authority
Cardano Founder Criticizes Ripple CEO’s Support, Warning of Excessive SEC Control in Proposed Legislation
A dispute has emerged in the cryptocurrency sector surrounding the Senate’s Clarity Act draft, with prominent figures like Cardano's Charles Hoskins...
Investor Dan Niles Highlights Key Turnaround and Tech Stocks for 2026 Amid Market Volatility
Amid Expectations of a Turbulent Market, Niles Identifies Apple, Cisco, Boeing, and Others as Prime Opportunities
Veteran investor Dan Niles projects a bifurcated 2026 market environment characterized by initial liquidity-driven gains followed by significant volat...
Navigating Required Minimum Distributions: Timing Strategies for 2026
Evaluating the Pros and Cons of Early Versus Late Withdrawals from Retirement Accounts
Required minimum distributions (RMDs) obligate individuals aged 73 and older to withdraw specified amounts from tax-deferred retirement accounts annua...
Harbour BioMed Increases Equity Stake in Spruce Biosciences Amid Strategic Collaborations
Hong Kong biotech firm deepens investment in Spruce Biosciences as partnerships with AstraZeneca and Bristol Myers Squibb advance
Harbour BioMed, a Hong Kong-based biotechnology company, has exercised warrants to acquire additional common stock in Spruce Biosciences Inc., elevati...